Soligenix
Developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Learn more
Launch date
Employees
Market cap
CAD10.7m
Enterprise valuation
CAD2m (Public information from Sep 2024)
Share price
$3.83 SNGX
Princeton New Jersey (HQ)
Authorizing premium user...